Myeloid Differentiation Primary Response Protein MyD88 (MYD88) Antibody

286€ (100 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Myeloid Differentiation Primary Response Protein MyD88 (MYD88) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx130079
tested applications
WB, IHC, IF/ICC
Description
Myeloid Differentiation Factor 88 Antibody is a Rabbit Polyclonal against Myeloid Differentiation Factor 88.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Primary Antibodies |
Immunogen Target | Myeloid Differentiation Primary Response Protein MyD88 (MYD88) |
Host | Rabbit |
Reactivity | Rat |
Recommended Dilution | WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Polyclonal |
Conjugation | Unconjugated |
Purification | Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography. |
Size 1 | 100 µl |
Size 2 | 200 µl |
Size 3 | 1 ml |
Form | Liquid |
Tested Applications | WB, IHC, IF/ICC |
Buffer | 0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol. |
Availability | Shipped within 5-7 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
UniProt ID | Q6Y1S1 |
Alias | MYD88D,MYD88 innate immune signal transduction adaptor, IMD68 |
Background | Antibody anti-MYD88 |
Status | RUO |
Descripción
MYD88 is a key adaptor protein involved in innate immune signaling downstream of Toll-like receptors (TLRs) and interleukin-1 receptors (IL-1Rs). It contains a death domain (DD) and a Toll/IL-1 receptor (TIR) domain, enabling interaction with upstream receptors and downstream signaling proteins. Upon activation, MYD88 recruits IRAK kinases (IRAK1/IRAK4) and TRAF6, leading to activation of NF-κB, MAPK, and JNK pathways, which regulate inflammation, cytokine production, and cell survival. MYD88 is essential for host defense against bacterial, viral, and fungal infections. Mutations in MYD88 are associated with immune dysregulation, such as autoimmune diseases and lymphomas, including Waldenström macroglobulinemia. Knockout studies show impaired immune responses, increased susceptibility to infections, and defects in pro-inflammatory cytokine production, underscoring MYD88's central role in innate immunity.
Related Products

Human MYD88(Myeloid differentiation primary response protein MyD88) ELISA Kit
Ver Producto
Mouse Myd88(Myeloid differentiation primary response protein MyD88) ELISA Kit
Ver Producto